Antigen-Specific Antibody Glycosylation Is Regulated via Vaccination
Alison E. Mahan(Ragon Institute of MGH, MIT and Harvard), Galit Alter(Ragon Institute of MGH, MIT and Harvard), Hanneke Schuitemaker(Johnson & Johnson (Israel)), Bruce D. Walker(Howard Hughes Medical Institute), Dagna Laufer(International AIDS Vaccine Initiative), Dan H. Barouch(Beth Israel Deaconess Medical Center), Maria Grazia Pau, Amy W. Chung(The University of Melbourne), Madeleine F. Jennewein(Advanced Energy (United States)), Kendall Dionne(Ragon Institute of MGH, MIT and Harvard), Todd J. Suscovich, Hendrik Streeck(University Hospital Bonn), Lindsey R. Baden(Brigham and Women's Hospital), Jacquelynne Tedesco(Ragon Institute of MGH, MIT and Harvard), Don Francis(Global Solutions for Infectious Diseases), Patricia Fast(International AIDS Vaccine Initiative)
Cited by 149
Related Papers
Safety and Efficacy of Single-Dose Ad26.COV2.S Vaccine against Covid-19
|New England Journal of Medicine|2021|2.6k
Persistence and Evolution of SARS-CoV-2 in an Immunocompromised Host
|New England Journal of Medicine|2020|1.4k
Immune correlates analysis of the mRNA-1273 COVID-19 vaccine efficacy clinical trial
|Science|2022|1.2k
DNA vaccine protection against SARS-CoV-2 in rhesus macaques
|Science|2020|1.1k
Infectious Diseases Society of America Guidelines on the Treatment and Management of Patients With COVID-19 (April 2020)
|Clinical Infectious Diseases|2020|1.1k